Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy

NCT02348073 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity
ADHD Inattention or Mixed Type
Epilepsy
Child

Interventions

DRUG: Vayarin®, supplementation of n-3 PUFA
DRUG: PLACEBO

Sponsor

Hospices Civils de Lyon